News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
123 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Deals
Booming Drug Sales Make This San Diego Biotech a Prime M&A Target
Neurocrine’s third-quarter financial results didn’t just impress, they blew everybody away.
November 3, 2017
·
2 min read
·
Mark Terry
Biotech Bay
How Gilead Lost $7.8B in October Alone
Gilead Sciences’ third-quarter financial results were dismal, to say the least.
November 3, 2017
·
2 min read
·
Mark Terry
Genetown
This is the Precision Medicine Biotech That’s Revolutionizing Cancer Treatment
Cancer treatment is moving rapidly toward personalized medicine and precision medicine thanks to genetic insight.
November 3, 2017
·
1 min read
Business
Intra-Cellular Therapies to Host Third Quarter 2017 Financial Results Conference Call and Webcast
To access the live conference call via phone, dial 1-(844) 835-6563.
November 3, 2017
·
1 min read
Job Trends
Bay Area’s Zymergen Opens Up Shop in Seattle to Accommodate Growth
A little more than one year after securing $130M in financing, molecular technology company Zymergen has expanded beyond the Golden State to the Emerald City, Seattle.
November 3, 2017
·
2 min read
·
Alex Keown
Business
Axovant Announces Second Fiscal Quarter Financial Results and Corporate Updates
Strong balance sheet with $235.4 million of cash as of September 30, 2017 supports Company’s current clinical development plans and business development activities.
November 3, 2017
·
7 min read
Deals
Two China Companies to Bid in $765 Million Auction for I-Med Radiology of Australia
Tonghua Golden-Horse Pharma and Golden Meditech Holdings -- will submit bids in the second round of an auction to acquire I-MED Radiology.
November 3, 2017
·
1 min read
Career Advice
Interview Insider: Tips on How to Get Hired by Sanofi
Here are some tips for getting in the door at one of the top international pharmas in the world.
November 3, 2017
·
5 min read
·
Mark Terry
Pharm Country
J&J Exec Reveals How You Can Stand Out Among 3,000 Job Seekers
Once upon a time, before the internet, you typically heard of a job through your local newspaper.
November 3, 2017
·
4 min read
·
Mark Terry
Annoroad, a Beijing Gene Services Company, Raises $100M in C Round
Annoroad raised $100M in a Series C financing, led by SAIF Partners and joined by SBCVC, Shenzhen GTJA Investment Group and Ping An Ventures.
November 3, 2017
·
1 min read
1 of 13
Next